Neuren Pharmaceuticals | NEU - Przychody Ze Sprzedaży





Obroty Zmiana Data
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Clinuvel Pharmaceuticals AUD 36.93M 22.44M 2025-12
Dianthus Therapeutics USD 463K 179K 2026-03
Genetic Signatures AUD 11.19M 5.56M 2025-12
Ionis Pharmaceuticals USD 268M 22M 2026-06
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organon & Co USD 1.56B 100M 2026-06
Paradigm Biopharmaceuticals AUD 284.06K 292.06K 2025-12
PYC Therapeutics AUD 11.04M 2.44M 2025-12
Starpharma Holdings AUD 10.83M 9.12M 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Telix Pharmaceuticals AUD 477.35M 63.92M 2026-06
Viatris USD 3.76B 240M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03